FL
LLY icon

FreeGulliver LLC’s Eli Lilly LLY Stock Holding History

FreeGulliver LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,500
Closed -$1.24M – 91
2025
Q1 		$1.24M Sell
1,500
-15,900
-91% -$13.2M 0.61% 23
2024
Q4 		$13.4M Buy
+17,400
New +$14.4M 6.4% 3

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FreeGulliver LLC's LLY Position: Q2 2026 in Review

FreeGulliver LLC reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $72.5K and leaving 571 shares worth $685K. The position accounts for 0.24% of the portfolio, ranked #47.

FreeGulliver LLC first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FreeGulliver LLC held 571 shares of Eli Lilly worth $685K as of Q2 2026.
  • FreeGulliver LLC sold 71 Eli Lilly shares in Q2 2026, an estimated $72.5K.
  • Eli Lilly made up 0.24% of FreeGulliver LLC's portfolio in Q2 2026, its #47 holding.
  • FreeGulliver LLC first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FreeGulliver LLC's 13F filing for Q2 2026, filed 11 Aug 2026.